Safety and adverse events following COVID-19 vaccination and epilepsy: Correspondence
We would like to discuss “Safety and Adverse Events Following COVID-19 Vaccination among People with Epilepsy: A Cross-Sectional Study.”1 The COVID-19 vaccination is safe for PWE, according to Ong et al. Following COVID-19 immunization, AEFI among PWE are comparable to those in the general population; thus, doctors should advise their PWE patients to receive COVID-19. Co-morbidity might be challenging to manage, so it is crucial to look at any potential COVID-19 vaccine problems.2 This is frequently not an option if a clinical problem arises after the vaccination. It is imperative to screen out any underlying diseases or likely co-morbidities that could lead to a clinical problem before vaccination. There is still a chance that SARS-Co-V2 patients go undetected and show no symptoms. Co-morbidity is occasionally mistakenly thought to have a detrimental effect, and other sources are easily misconstrued.3 Recent studies4 have also connected underlying genetic variation to recipients' immune responses to the COVID-19 vaccine. Future studies should consider the many genetic background elements that migth relate to reaction to the vaccine.
CONFLICT OF INTEREST
Neither of the authors has any conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. You will find our policy on ethical publication in our instructions for authors.
